S100A4/FSP1: A Prognostic Marker and a Promising Target for Antitumor Therapy

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Exploring the Heterogeneity of Cancer-Associated Fibroblasts via Development of Patient-Derived Cell Culture of Breast Cancer2025 · 4 citations
2. 2Effect of Mts1 on the Structure and Activity of Nonmuscle Myosin II1997 · 89 citations
3. 3The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment2021 · 705 citations
4. 4S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus2022 · 12 citations
5. 5Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis2022 · 33 citations